Abstract
Background: Bone reconstruction following a wide resection for a malignant musculoskeletal tumor remains challenging, especially for an intercalary defect following the resection of a metaphyseal lesion. Case Report: Here, we describe a surgical procedure using the Masquelet technique for the biological reconstruction of a huge subtrochanteric bone defect following failed pasteurized autologous bone grafting for a conventional chondrosarcoma of the proximal femoral metaphysis with a subtrochanteric pathological fracture. The patient, a 43-year-old Japanese male, was able to walk without a cane or a brace at 15 months after the final operation (International Society of Limb Salvage score, 86.7%). Conclusion: This procedure should be considered as one of the reconstruction options following the wide resection of malignant bone tumors located in the metaphysis.
- Masquelet technique
- induced membrane
- biological reconstruction
- malignant bone tumor
- huge bone defect
- metaphysis
- adult
Bone reconstruction following a wide resection for a musculoskeletal malignancy is difficult and challenging. Surgical options are broadly classified into two groups: megaprosthetic reconstruction and biological reconstruction. A marked improvement of patients' vital prognoses by multidisciplinary treatment and biological reconstruction is in demand. However, when the biological reconstruction has failed, the re-reconstruction methods for the remaining bone defect are limited.
The ‘Masquelet technique’, also known as the ‘induced membrane technique’, is one of the surgical techniques used for reconstructing bone defects. This technique was originally reported by Masquelet et al. in 2000 (1) as a method for reconstructing bone defects in the chronic phase following trauma (e.g., septic non-union after an open fracture). Thereafter, the Masquelet technique has also been applied for the primary treatment of open fractures with a bone defect (2, 3). Apart from trauma cases, this technique has been applied for bone defects after the resection of malignant bone tumors, mainly in pediatric patients (4-7), but a small number of adult patients has also undergone this technique with favorable outcomes (8). The Masquelet procedure consists of two stages (9, 10). In the first-stage, surgery is performed and the affected bone is removed and the bone defect is filled with polymethylmethacrylate (PMMA) cement. In the second-stage, surgery is performed 6-8 weeks later and the induced membrane around the PMMA cement is incised and the PMMA cement is removed; autologous cancellous bone is grafted, and the induced membrane is sutured. Although this procedure requires two separate surgeries, the procedure itself is quite simple.
Here, we describe a surgical procedure using the Masquelet technique for the biological reconstruction of a huge subtrochanteric bone defect following failed pasteurized autologous bone grafting, in a case of conventional chondrosarcoma with a pathological fracture.
Case Report
A previously healthy 43-year-old Japanese man slipped and fell on frozen ground. He was transported to the emergency room of the primary hospital and diagnosed with a bone tumor with a left subtrochanteric pathological fracture. Since the needle biopsy specimen was pathologically diagnosed as a low-grade conventional chondrosarcoma (grade 1), the patient was referred to our hospital. Plain radiographs revealed an osteolytic lesion with cortical ballooning on the left proximal femur and a subtrochanteric pathological fracture (Figure 1A, B). Magnetic resonance imaging revealed a bone tumor without extracortical extension, measuring approx. 140×29×31 mm (Figure 1C). Chest computed tomography, as an additional radiological examination, revealed no other tumorous regions throughout the entire body.
Initial plain radiography shows a metaphyseal osteolytic lesion with cortical ballooning and subtrochanteric pathological fracture on anteroposterior (A) and lateral (B) imaging. Coronal T1-weighted MRI (C) reveals the intraosseous tumor without extracortical extension. Lines indicate the osteotomy line (arrows).
Three weeks after the fracture, the patient underwent surgical treatment for the removal of the tumor. In the preoperative planning, we expected to encounter a 17-cm bone defect after performing an en-bloc wide resection of the tumor and circumferential soft tissues. Although megaprosthetic reconstruction was also considered, we eventually selected pasteurized autologous bone grafting and bone fixation with an intramedullary interlocking nail and locking plate for the preservation of the patient's hip joint function (Figure 2).
The patient's lower extremity was kept non-weight-bearing and low-intensity pulsed ultrasound was also used; however, his grafted bone was gradually resorbed from 3 months after the operation (Figure 3). To preserve the patient's hip joint function, we decided to perform a biological reconstruction with the Masquelet technique after the removal of resorbing bone. Eight months after the operation, the resorbed bone was removed, and both the intramedullary interlocking nail and locking plate were left in place (Figure 4A, B). The huge 17-cm bone defect was filled with PMMA cement that contained 1 g of vancomycin per 40 g of PMMA cement (as part of the first-stage surgery) (Figure 4C, D). At 8 weeks after the first-stage surgery, a second-stage surgery was performed as follows. We incised the induced membrane around the PMMA cement, carefully removed the PMMA cement, grafted autologous cancellous bone, and sutured the induced membrane. Although 155 g of autologous cancellous bone was harvested from the bilateral anterior and posterior iliac crest, it was not sufficient; thus, 56 g of artificial bone (beta-tricalcium phosphate, β-TCP) was additionally used (approx. 3:1 ratio) (Figure 5). After the final operation, consolidation was gradually observed (Figure 6), and full-weight bearing was permitted 6 months after the final operation.
The physical examination at 15 months after the final operation showed that the active range of motion of the patient's hip and knee were extension 20°/flexion 120° and extension 0°/flexion 135°, respectively, and the extension and abduction muscular strength of the hip was evaluated as 5/5 and 4/5 in a manual muscle test, respectively. The patient was able to walk without a cane or a brace. Limb function was determined to be 86.7% according to the International Society of Limb Salvage (11). There was no indication of local or distant recurrence at 37 months after the first operation (tumor resection).
Plain radiography after the initial operation on anteroposterior (A) and lateral (B) imaging. After the wide resection and subsequent extracorporeal pasteurization, the treated autologous bone was fixed with an intramedullary interlocking nail and locking plate.
Anteroposterior plain radiography obtained at 1 (A), 3 (B) and 7 (C) months after the initial operation shows gradual resorption of the treated bone starting at 3 months after the surgery (arrows).
Discussion
Wide resection is the standard procedure for malignant bone tumors. The progress in multidisciplinary approaches has enabled salvaging of limbs in many cases. There are established procedures for reconstructing a bone defect after a wide resection. Megaprosthetic reconstruction is one of the most commonly used procedures, and it has provided favorable treatment outcomes. However, as a result of the marked improvement of patients' vital prognoses by multidisciplinary treatment, longstanding problems such as soft-tissue failure, aseptic loosening, implant breakage, periprosthetic fracture, and/or infection become unavoidable (12). In fact, a recent systematic review has indicated that the 10-year implant survival rate of proximal femoral megaprosthesis was 55%-86% (13). Other reconstruction procedures that can replace the use of megaprosthesis are thus required. The avoidance of megaprosthetic reconstruction for an intercalary bone defect after the resection of a metaphyseal lesion may allow preservation of the adjacent joint.
In the first-stage surgery using the Masquelet technique, absorbed bone (A) was removed and the 17-cm bone defect (B) was filled with PMMA cement (C, D).
The reconstruction of an intercalary bone defect is another challenging problem. Although a segmental prosthesis is a possible surgical option, it cannot be applied for the metaphysis. The design of 3D-printed custom-made implants continues to advance (14). Biological reconstruction is now frequently used because of its favorable long-term functional outcome. Among the available biological reconstruction techniques, bulk allograft bone is globally used. However, in Asian countries including Japan, socio-religious reasons limit the use of allograft bone, and devitalized autologous tumor-bearing bone has been widely used. Nowadays, irradiation, pasteurization, or freezing with liquid nitrogen are used as devitalizing methods for tumor-bearing autologous bone in clinical settings (15). Other biological reconstruction procedures such as a free vascularized fibular graft or segmental bone transportation (distraction osteogenesis) are also available (15), but these are complicated surgical procedures, and there are limits on both surgeons and medical institutions. The clinical outcomes of treated autologous bone grafting have been reported to be favorable, but some types of failure such as nonunion in the junction, graft fracture, bone absorption, or infection may occur before the revitalization and maturation (15). In the failed cases, re-reconstruction methods after removing the failed treated autologous bone are limited. Although distraction osteogenesis or free vascularized bone grafting (e.g., with the fibula) are used for the biological reconstruction in a limited number of cases, megaprosthetic reconstruction (or sometimes amputation/disarthrocation) is selected in most cases.
In the second-stage surgery, after the removal of the PMMA cement, the bone defect was filled with a mixture of autologous cancellous bone and artificial bone (A-C).
In our patient's case, it was possible the resected bone to be used for treated autologous tumor-bearing bone grafting because of its advanced osteolysis and pathological fracture (15). However, we had plotted the therapeutic strategy considering the preservation of hip joint function as a top priority. Since bone resorption had gradually advanced as a result, we continued this therapeutic strategy. Intercalary biological reconstruction with the Masquelet technique was finally performed.
It was originally reported that the Masquelet technique can be indicated for huge bone defects, although conventional autologous bone grafting for diaphyseal bone defects >6 cm may lead to incomplete healing (9). Kargar et al. have reported that the bone union success rate was not affected by the length of bone defects (16). However, in our institutional experience, the total amount of autologous cancellous bone harvested from the bilateral anterior and posterior iliac crest is limited, and it can be used only for segmental bone defects <6 cm (3). Therefore, in the present case, we used β-TCP together with the harvested autologous cancellous bone as a bone substitute (9, 17, 18) at an approx. 3:1 ratio for the 17-cm bone defect, and good consolidation was eventually achieved.
In cases treated with autologous bone grafting for the reconstruction of a bone defect, rigid internal fixation with multiple fracture fixation devices are recommended (19). In our experience, when re-reconstructing failed-treated autologous bone grafting, the preservation of such internal fixation devices may make it easier to maintain the alignment, rotation, and length of the affected limb (10).
Anteroposterior (A) and lateral (B) plain radiography and coronal (C), sagittal (D) and 3D (E) CT images obtained 1 year after the final operation show bone consolidation for the most part.
In conclusion, the Masquelet technique is a recommendable biological reconstruction method for salvaging failed-treated autologous tumor-bearing bone grafting as well as for the primary bone defect after a wide resection for a malignant bone tumor.
Footnotes
Authors' Contributions
MH operated the patient and wrote the manuscript. RK, NS, NT, YK, HY and SK were involved in a patient care, manuscript preparation and review. All Authors read and approved the final manuscript.
This article is freely accessible online.
Conflicts of Interest
The Authors state that they have no conflicts of interest to declare in regard to this study.
- Received June 30, 2020.
- Revision received August 4, 2020.
- Accepted August 5, 2020.
- Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.
